Success story or artificial inflation? Hospital performance in CAUTIs
A new study links changes in the way catheter-associated urinary tract infections (CAUTIs) are defined and artificially improved hospital performance scores.
Sep 16, 2019
0
0
A new study links changes in the way catheter-associated urinary tract infections (CAUTIs) are defined and artificially improved hospital performance scores.
Sep 16, 2019
0
0
Higher hospital-wide use of four classes of antibiotics thought to increase the risk of the dangerous intestinal illness Clostridioides difficile were associated with increased prevalence of hospital-associated C. difficile, ...
Sep 16, 2019
0
4
There is good news on the infection front: infections acquired by patients in Canadian hospitals are declining, with a 30% reduction between 2009 and 2017, according to new research in CMAJ (Canadian Medical Association Journal). ...
Sep 9, 2019
0
2
A new rapid patient test that could identify whether bacteria isolated from clinical samples are antibiotic resistant in under two hours is being trialled on a range of antibiotics commonly used to treat urinary tract infections ...
Aug 29, 2019
0
29
New, more effective antibiotics are being prescribed in only about a quarter of infections by carbapenem-resistant Enterobacteriaceae (CRE), a family of the world's most intractable drug-resistant bacteria, according to an ...
Aug 26, 2019
0
1
Scientists have shed new light on how mucosal infections can affect the body's inflammatory response to shape susceptibility to recurrence.
Aug 20, 2019
0
0
Sufferers of recurring urinary tract infections (UTIs) could expect more effective treatments thanks to University of Queensland-led research.
Aug 13, 2019
0
85
Doctors urgently need a fast and accurate test for diagnosing urinary tract infections (UTIs) to reduce overprescribing of antibiotics, according to health researchers.
Aug 13, 2019
0
2
(HealthDay)—Initiation of therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection (UTI) events compared with initiation ...
Jul 30, 2019
0
4
(HealthDay)—The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, ...
Jul 18, 2019
0
2